Plasmid containing CpG motifs enhances the efficacy of porcine reproductive and respiratory syndrome live attenuated vaccine

Veterinary Immunology and Immunopathology

Volumn 144, Issue 3-4, 2011, Pages 405-409

  Guo, Xiaoyu ^a,b   Zhang, Quan ^c   Hou, Shaohua ^a   Zhai, Guoqin ^c   Zhu, Hongfei ^a   Sanchez Vizcaino J M ^b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c YANGZHOU UNIVERSITY   (China)

Author keywords

Adjuvanticity; CpG motif; Immune response; Porcine reproductive and respiratory syndrome; Protection

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 6; LIVE VACCINE; PLASMID VECTOR; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOPSY; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; HUMORAL IMMUNITY; IMMUNOSTIMULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PROTEIN BLOOD LEVEL; VACCINATION; VIREMIA; VIRUS EXCRETION; VIRUS IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CPG ISLANDS; CYTOKINES; IMMUNITY, HUMORAL; PLASMIDS; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; VACCINES, ATTENUATED; VIRAL VACCINES;

PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS;

EID: 81555198383     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.07.023     Document Type: Article

References (19)

1. Cancel-Tirado S.M., Evans R.B., Yoon K.J. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection. Vet. Immunol. Immunopathol. 2004, 102:249-262.
2. Corral R.S., Petray P.B. CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine 2000, 19:234-242.
3. Diaz I., Darwich L., Pappaterra G., Pujols J., Mateu E. Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2005, 86:1943-1951.
4. Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol. 2002, 39:531-536.
5. Kimman T.G., Cornelissen L.A., Moormann R.J., Rebel J.M., Stockhofe-Zurwieden N. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine 2009, 27:3704-3718.
6. Krieg A.M. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 2006, 5:471-484.
7. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
8. Li Y., Wang X., Bo K., Tang B., Yang B., Jiang W., Jiang P. Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China. Vet. J. 2007, 174:577-584.
9. Linghua Z., Xingshan T., Yong G., Fengzhen Z. Effects of CpG ODN on CD4+ and CD8+ T subpopulations in the immune response to porcine reproductive and respiratory syndrome killed virus vaccine. Vaccine 2006, 24:1874-1879.
10. Madsen K.G., Hansen C.M., Madsen E.S., Strandbygaard B., Botner A., Sorensen K.J. Sequence analysis of porcine reproductive and respiratory syndrome virus of the American type collected from Danish swine herds. Arch. Virol. 1998, 143:1683-1700.
11. Mardassi H., Mounir S., Dea S. Identification of major differences in the nucleocapsid protein genes of a Quebec strain and European strains of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 1994, 5(Pt 3):681-685.
12. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
13. Quan Z., Qin Z.G., Zhen W., Feng X.Z., Hong J., Fei Z.H. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine. Vet. Immunol. Immunopathol. 2010, 136:257-264.
14. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 2001, 11:333-340.
15. Weeratna R., Comanita L., Davis H.L. CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice. Immunol. Cell Biol. 2003, 81:59-62.
16. Yang S.X., Kwang J., Laegreid W. Comparative sequence analysis of open reading frames 2 to 7 of the modified live vaccine virus and other North American isolates of the porcine reproductive and respiratory syndrome virus. Arch. Virol 1998, 143:601-612.
17. Yoo D., Song C., Sun Y., Du Y., Kim O., Liu H.C. Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus. Virus Res. 2010, 154:48-60.
18. Zhang Q., Yu K., Yuan W., Xue F., Sun H., Zhu H. Purification of large-scale plasmid DNAs by selective precipitation with cetyltrimethylammonium bromide. Sheng Wu Gong Cheng Xue Bao 2008, 24:2117-2121.
19. Zuckermann F.A., Garcia E.A., Luque I.D., Christopher-Hennings J., Doster A., Brito M., Osorio F. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet. Microbiol. 2007, 123:69-85.